REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $366,712 | -15.3% | 22,279 | +2.9% | 0.00% | -33.3% |
Q2 2023 | $432,943 | +5.2% | 21,658 | -0.5% | 0.00% | 0.0% |
Q1 2023 | $411,633 | -16.2% | 21,768 | +0.5% | 0.00% | 0.0% |
Q4 2022 | $491,067 | -14.9% | 21,652 | -0.7% | 0.00% | -25.0% |
Q3 2022 | $577,000 | +8.3% | 21,813 | +1.0% | 0.00% | 0.0% |
Q2 2022 | $533,000 | -28.6% | 21,597 | -3.9% | 0.00% | 0.0% |
Q1 2022 | $746,000 | -4.4% | 22,472 | -5.8% | 0.00% | 0.0% |
Q4 2021 | $780,000 | -24.4% | 23,860 | -3.1% | 0.00% | -33.3% |
Q3 2021 | $1,032,000 | +5.3% | 24,612 | -2.4% | 0.01% | +100.0% |
Q2 2021 | $980,000 | +12.9% | 25,220 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $868,000 | -15.2% | 25,439 | +12.8% | 0.00% | -25.0% |
Q4 2020 | $1,023,000 | +60.8% | 22,551 | -2.5% | 0.00% | +33.3% |
Q3 2020 | $636,000 | -27.6% | 23,120 | -3.1% | 0.00% | -25.0% |
Q2 2020 | $879,000 | +19.3% | 23,854 | +4.8% | 0.00% | 0.0% |
Q1 2020 | $737,000 | -24.8% | 22,765 | -4.8% | 0.00% | 0.0% |
Q4 2019 | $980,000 | +12.3% | 23,908 | -2.5% | 0.00% | 0.0% |
Q3 2019 | $873,000 | -31.3% | 24,520 | -0.9% | 0.00% | -20.0% |
Q2 2019 | $1,270,000 | -7.9% | 24,731 | +2.8% | 0.01% | 0.0% |
Q1 2019 | $1,379,000 | +33.2% | 24,062 | -2.4% | 0.01% | +25.0% |
Q4 2018 | $1,035,000 | -44.2% | 24,664 | +0.3% | 0.00% | -33.3% |
Q3 2018 | $1,856,000 | +18.6% | 24,589 | +12.7% | 0.01% | +20.0% |
Q2 2018 | $1,565,000 | +194.7% | 21,814 | +22.7% | 0.01% | +150.0% |
Q1 2018 | $531,000 | -13.8% | 17,776 | -4.1% | 0.00% | 0.0% |
Q4 2017 | $616,000 | +1.3% | 18,538 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $608,000 | +80.4% | 18,451 | +8.1% | 0.00% | +100.0% |
Q2 2017 | $337,000 | +39.8% | 17,071 | +36.9% | 0.00% | 0.0% |
Q1 2017 | $241,000 | +11.6% | 12,468 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $216,000 | -99.9% | 11,646 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $163,595,000 | +75.4% | 11,677 | +0.1% | 0.00% | – |
Q2 2016 | $93,280,000 | +107.3% | 11,660 | +178.4% | 0.00% | – |
Q1 2016 | $45,000,000 | – | 4,188 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |